Aravofloxacin

A fluoroquinolone antibiotic

Aravofloxacin
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Aravofloxacin is a fluoroquinolone antibiotic that was under development for the treatment of bacterial infections. It is a synthetic antibacterial agent that belongs to the class of quinolone antibiotics, which are known for their broad-spectrum activity against a variety of Gram-positive and Gram-negative bacteria.

Mechanism of Action

Aravofloxacin, like other fluoroquinolones, works by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes that are essential for bacterial DNA replication, transcription, and repair. By interfering with these critical processes, aravofloxacin effectively halts bacterial cell division and leads to cell death.

Pharmacokinetics

Aravofloxacin is designed to be administered orally, and it exhibits good absorption from the gastrointestinal tract. Once absorbed, it is distributed throughout the body, reaching effective concentrations in various tissues and fluids. The drug is primarily eliminated through the kidneys, and its half-life allows for convenient dosing schedules.

Clinical Development

Aravofloxacin was being developed for the treatment of community-acquired pneumonia and other respiratory tract infections. However, its development was discontinued during clinical trials. The reasons for discontinuation are not publicly detailed, but it is common for drug development to be halted due to issues such as lack of efficacy, safety concerns, or strategic business decisions.

Potential Uses

Although aravofloxacin is not currently available on the market, its broad-spectrum activity suggests potential utility in treating infections caused by resistant bacterial strains. Fluoroquinolones are often used in cases where other antibiotics are ineffective, making them valuable in the fight against antibiotic resistance.

Safety and Side Effects

As with other fluoroquinolones, aravofloxacin may be associated with side effects such as gastrointestinal disturbances, central nervous system effects, and potential tendon damage. The safety profile of aravofloxacin would have been thoroughly evaluated during its clinical trials.

Related pages

• Fluoroquinolone
• Antibiotic resistance
• Community-acquired pneumonia